"Machado-Joseph Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A dominantly-inherited ATAXIA first described in people of Azorean and Portuguese descent, and subsequently identified in Brazil, Japan, China, and Australia. This disorder is classified as one of the SPINOCEREBELLAR ATAXIAS (Type 3) and has been associated with a mutation of the MJD1 gene on chromosome 14. Clinical features include progressive ataxia, DYSARTHRIA, postural instability, nystagmus, eyelid retraction, and facial FASCICULATIONS. DYSTONIA is prominent in younger patients (referred to as Type I Machado-Joseph Disease). Type II features ataxia and ocular signs; Type III features MUSCULAR ATROPHY and a sensorimotor neuropathy; and Type IV features extrapyramidal signs combined with a sensorimotor neuropathy. (From Clin Neurosci 1995;3(1):17-22; Ann Neurol 1998 Mar;43(3):288-96)
Descriptor ID |
D017827
|
MeSH Number(s) |
C10.228.140.252.190.530.530 C10.228.140.252.700.700.500 C10.228.854.787.875.500 C10.574.500.825.700.500 C10.597.350.090.500.530.530 C16.320.400.780.875.500
|
Concept/Terms |
Machado-Joseph Disease- Machado-Joseph Disease
- Disease, Machado-Joseph
- Machado Joseph Disease
- Joseph Azorean Disease
- Disease, Joseph Azorean
- Joseph Disease
- Disease, Joseph
- Spinocerebellar Ataxia Type 3
- Striatonigral Degeneration, Autosomal Dominant
- Autosomal Dominant Striatonigral Degeneration
- Azorean Disease, Nervous System
- Machado-Joseph Azorean Disease
- Disease, Machado-Joseph Azorean
- Machado Joseph Azorean Disease
- Nervous System Azorean Disease
- Spinocerebellar Ataxia-3
- Type 3 Spinocerebellar Ataxia
- Azorean Disease (Machado-Joseph)
- Azorean Disease (Machado Joseph)
- Disease, Azorean (Machado-Joseph)
- Spinocerebellar Atrophy Type 3
- Azorean Neurologic Disease
- Disease, Azorean Neurologic
- Neurologic Disease, Azorean
- Nigrospinodentatal Degeneration
- Degeneration, Nigrospinodentatal
- Degenerations, Nigrospinodentatal
- Nigrospinodentatal Degenerations
- Spinocerebellar Ataxia 3
- 3s, Spinocerebellar Ataxia
- Ataxia 3, Spinocerebellar
- Ataxia 3s, Spinocerebellar
- Spinocerebellar Ataxia 3s
- Spinocerebellar Atrophy III
- Atrophy III, Spinocerebellar
- Atrophy IIIs, Spinocerebellar
- III, Spinocerebellar Atrophy
- Spinocerebellar Atrophy IIIs
- Azorean Ataxia
- Azorean Disease
- Disease, Azorean
Machado-Joseph Disease Type IV- Machado-Joseph Disease Type IV
- Machado Joseph Disease Type IV
- Type IV Machado-Joseph Disease
- Type IV Machado Joseph Disease
Machado-Joseph Disease Type III- Machado-Joseph Disease Type III
- Machado Joseph Disease Type III
- Type III Machado-Joseph Disease
- Type III Machado Joseph Disease
Machado-Joseph Disease Type I- Machado-Joseph Disease Type I
- Machado Joseph Disease Type I
- Type I Machado-Joseph Disease
- Type I Machado Joseph Disease
Machado-Joseph Disease Type II- Machado-Joseph Disease Type II
- Machado Joseph Disease Type II
- Type II Machado-Joseph Disease
- Type II Machado Joseph Disease
|
Below are MeSH descriptors whose meaning is more general than "Machado-Joseph Disease".
Below are MeSH descriptors whose meaning is more specific than "Machado-Joseph Disease".
This graph shows the total number of publications written about "Machado-Joseph Disease" by people in this website by year, and whether "Machado-Joseph Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1998 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
2002 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2015 | 5 | 1 | 6 |
2016 | 1 | 0 | 1 |
2017 | 2 | 1 | 3 |
2018 | 3 | 0 | 3 |
2019 | 1 | 0 | 1 |
2020 | 3 | 0 | 3 |
2021 | 1 | 0 | 1 |
2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Machado-Joseph Disease" by people in Profiles.
-
Synaptic Loss in Spinocerebellar Ataxia Type 3 Revealed by SV2A Positron Emission Tomography. Mov Disord. 2023 06; 38(6):978-989.
-
Baseline Clinical and Blood Biomarkers in Patients With Preataxic and Early-Stage Disease Spinocerebellar Ataxia 1 and 3. Neurology. 2023 04 25; 100(17):e1836-e1848.
-
DNAzyme Cleavage of CAG Repeat RNA in Polyglutamine Diseases. Neurotherapeutics. 2021 07; 18(3):1710-1728.
-
Analysis of diffusion tensor parameters in spinocerebellar ataxia type 3 and type 10 patients. Parkinsonism Relat Disord. 2020 09; 78:73-78.
-
Deficiency in classical nonhomologous end-joining-mediated repair of transcribed genes is linked to SCA3 pathogenesis. Proc Natl Acad Sci U S A. 2020 04 07; 117(14):8154-8165.
-
The impact of ethnicity on the clinical presentations of spinocerebellar ataxia type 3. Parkinsonism Relat Disord. 2020 03; 72:37-43.
-
Olfactory Function in SCA10. Cerebellum. 2019 Feb; 18(1):85-90.
-
Polymorphisms in DNA methylation-related genes are linked to the phenotype of Machado-Joseph disease. Neurobiol Aging. 2019 03; 75:225.e1-225.e8.
-
Body composition in Spinocerebellar ataxia type 3 and 10 patients: Comparative study with control group. Nutr Neurosci. 2020 Jan; 23(1):49-54.
-
Spinocerebellar ataxias type 3 and 10: Onset and progression of ataxia during pregnancy and puerperium. Parkinsonism Relat Disord. 2018 07; 52:119-120.